|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-11-6
|
|
pubmed:abstractText |
We studied 15 patients with chronic coronary artery disease (13 men aged 62 +/- 8 years) undergoing dobutamine (5 to 40 microg/kg/min) echocardiography at the end of two 15-day treatment periods with placebo and trimetazidine (20 mg 3 times daily) given in random order, according to a double-blind, crossover design. Results show that trimetazidine improves resting left ventricular function and reduces the severity of dobutamine-induced ischemic myocardial dysfunction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0002-9149
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
898-901
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9781975-Administration, Oral,
pubmed-meshheading:9781975-Coronary Disease,
pubmed-meshheading:9781975-Cross-Over Studies,
pubmed-meshheading:9781975-Dobutamine,
pubmed-meshheading:9781975-Drug Administration Schedule,
pubmed-meshheading:9781975-Echocardiography,
pubmed-meshheading:9781975-Female,
pubmed-meshheading:9781975-Humans,
pubmed-meshheading:9781975-Male,
pubmed-meshheading:9781975-Middle Aged,
pubmed-meshheading:9781975-Trimetazidine,
pubmed-meshheading:9781975-Vasodilator Agents,
pubmed-meshheading:9781975-Ventricular Dysfunction, Left
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease.
|
|
pubmed:affiliation |
Istituto Scientifico H. San Raffaele, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
